ACHN - Achillion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
0
15,000
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
57,947
50,118
65,052
59,162
Selling General and Administrative
22,298
23,896
24,524
20,703
Total Operating Expenses
80,245
74,014
89,576
79,865
Operating Income or Loss
-80,245
-74,014
-89,576
-64,865
Interest Expense
29
36
50
68
Total Other Income/Expenses Net
-655
-1,900
-
0
Income Before Tax
-74,569
-70,272
-85,236
-61,706
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-74,569
-70,272
-85,236
-61,706
Net Income
-74,569
-70,272
-85,236
-61,706
Net Income available to common shareholders
-74,569
-70,272
-85,236
-61,706
Reported EPS
Basic
-
-0.51
-0.62
-0.45
Diluted
-
-0.51
-0.62
-0.45
Weighted average shares outstanding
Basic
-
138,418
137,180
136,667
Diluted
-
138,418
137,180
136,667
EBITDA
-
-69,078
-84,060
-60,683